165 related articles for article (PubMed ID: 9798958)
1. Curvature in the cancer mortality dose response in Japanese atomic bomb survivors: absence of evidence of threshold.
Little MP; Muirhead CR
Int J Radiat Biol; 1998 Oct; 74(4):471-80. PubMed ID: 9798958
[TBL] [Abstract][Full Text] [Related]
2. Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors.
Little MP; Muirhead CR
Int J Radiat Biol; 1996 Jul; 70(1):83-94. PubMed ID: 8691040
[TBL] [Abstract][Full Text] [Related]
3. Derivation of low-dose extrapolation factors from analysis of curvature in the cancer incidence dose response in Japanese atomic bomb survivors.
Little MP; Muirhead CR
Int J Radiat Biol; 2000 Jul; 76(7):939-53. PubMed ID: 10923618
[TBL] [Abstract][Full Text] [Related]
4. Threshold and other departures from linear-quadratic curvature in the non-cancer mortality dose-response curve in the Japanese atomic bomb survivors.
Little MP
Radiat Environ Biophys; 2004 Jul; 43(2):67-75. PubMed ID: 15221316
[TBL] [Abstract][Full Text] [Related]
5. Curvilinearity in the dose-response curve for cancer in Japanese atomic bomb survivors.
Little MP; Muirhead CR
Environ Health Perspect; 1997 Dec; 105 Suppl 6(Suppl 6):1505-9. PubMed ID: 9467073
[TBL] [Abstract][Full Text] [Related]
6. Projection of cancer risks from the Japanese atomic bomb survivors to the England and Wales population taking into account uncertainty in risk parameters.
Little MP; Deltour I; Richardson S
Radiat Environ Biophys; 2000 Dec; 39(4):241-52. PubMed ID: 11200968
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the degree of curvature in the cancer incidence dose-response in Japanese atomic bomb survivors with that in chromosome aberrations measured in vitro.
Little MP
Int J Radiat Biol; 2000 Oct; 76(10):1365-75. PubMed ID: 11057745
[TBL] [Abstract][Full Text] [Related]
8. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
9. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.
Preston DL; Pierce DA; Shimizu Y; Cullings HM; Fujita S; Funamoto S; Kodama K
Radiat Res; 2004 Oct; 162(4):377-89. PubMed ID: 15447045
[TBL] [Abstract][Full Text] [Related]
10. Flexible dose-response models for Japanese atomic bomb survivor data: Bayesian estimation and prediction of cancer risk.
Bennett J; Little MP; Richardson S
Radiat Environ Biophys; 2004 Dec; 43(4):233-45. PubMed ID: 15565453
[TBL] [Abstract][Full Text] [Related]
11. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
Little MP
Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
[TBL] [Abstract][Full Text] [Related]
12. Corrections in the atomic bomb data to examine low dose risk.
Baker GS; Hoel DG
Health Phys; 2003 Dec; 85(6):709-20. PubMed ID: 14626322
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
Little MP
Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
[TBL] [Abstract][Full Text] [Related]
14. Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors?
Little MP; Hall P; Charles MW
Radiat Environ Biophys; 2007 Nov; 46(4):299-310. PubMed ID: 17639450
[TBL] [Abstract][Full Text] [Related]
15. Radiation dose response estimation with emphasis on low dose range using restricted cubic splines: application to all solid cancer mortality data, 1950-2003, in atomic bomb survivors.
Nakashima E
Health Phys; 2015 Jul; 109(1):15-24. PubMed ID: 26011495
[TBL] [Abstract][Full Text] [Related]
16. New models for evaluation of radiation-induced lifetime cancer risk and its uncertainty employed in the UNSCEAR 2006 report.
Little MP; Hoel DG; Molitor J; Boice JD; Wakeford R; Muirhead CR
Radiat Res; 2008 Jun; 169(6):660-76. PubMed ID: 18494541
[TBL] [Abstract][Full Text] [Related]
17. Lifetime Mortality Risk from Cancer and Circulatory Disease Predicted from the Japanese Atomic Bomb Survivor Life Span Study Data Taking Account of Dose Measurement Error.
Little MP; Pawel D; Misumi M; Hamada N; Cullings HM; Wakeford R; Ozasa K
Radiat Res; 2020 Sep; 194(3):259-276. PubMed ID: 32942303
[TBL] [Abstract][Full Text] [Related]
18. The shape of the cancer mortality dose-response curve for the A-bomb survivors.
Pierce DA; Vaeth M
Radiat Res; 1991 Apr; 126(1):36-42. PubMed ID: 2020737
[TBL] [Abstract][Full Text] [Related]
19. Estimates of neutron relative biological effectiveness derived from the Japanese atomic bomb survivors.
Little MP
Int J Radiat Biol; 1997 Dec; 72(6):715-26. PubMed ID: 9416794
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
Little MP
Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
